| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought 2 open-market purchases by 2 insiders worth about $91K and no sales. The 12 months before that brought 5 open-market purchases by 3 insiders worth about $1.2M and no sales.
The largest open-market purchase in the last two years was 76,986 shares by Michael D Price (Director) at an average $6.49 on May 14, 2025, about $500K. Twelve months later OSG was down 13%.
The most recent purchase was by Claude LeBlanc (Chief Executive Officer) on January 2, 2026.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.07M | $5.37M | - | |
| CFO | 267.1K | $1.34M | - | |
| COO | 156.3K | $783.2K | - | |
| Other | 632 | $3.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Claude LeBlanc48 | Chief Executive Officer | Buy | 12,000 | $7.59 | $91,080.00 | +1.2% | -38.2% | - | |
| Nov 12, 2025 | R Sharon Smith50 | Executive VP & Group COO | Buy | 20 | $10.25 | $205.00 | - | -38.6% | - | |
| Oct 1, 2025 | Claude LeBlanc48 | Chief Executive Officer | Buy | 25,000 | $8.54 | $213,500.00 | +2.5% | -3.7% | -47.1% | |
| Aug 11, 2025 | Claude LeBlanc48 | Chief Executive Officer | Buy | 25,000 | $7.03 | $175,750.00 | +4.3% | +14.8% | -40.0% | |
| May 14, 2025 | Michael D Price | Director | Buy | 76,986 | $6.49 | $499,642.29 | +86.2% | +23.3% | -12.9% | |
| May 14, 2025 | Claude LeBlanc48 | Chief Executive Officer | Buy | 40,000 | $6.50 | $260,000.00 | +7.4% | +23.3% | -12.9% | |
| May 14, 2025 | Jeffrey Scott Stein | Director | Buy | 15,000 | $6.46 | $96,900.00 | +42.9% | +23.3% | -12.9% | |
| Sep 27, 2024 | Kristi Ann Matus | Director | Buy | 9,000 | $11.19 | $100,737.00 | New | +10.6% | -15.0% | |
| Aug 8, 2024 | R Sharon Smith50 | Executive VP & Chief Strategy Officer | Buy | 1,100 | $10.64 | $11,704.00 | +1.5% | +10.0% | -34.4% | |
| Aug 7, 2024 | Stephen Michael Ksenak | Sr. MD & General Counsel | Buy | 5,000 | $11.00 | $55,000.00 | +4.5% | +6.8% | -21.3% |